Updated Jul 16, 2026
Legorreta Pablo G. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Pablo G. Legorreta is the CEO and Chairman of the Board of Royalty Pharma plc, a leading buyer of biopharmaceutical royalties. He has played a significant role in the company's growth and strategic direction since its founding.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | RPRX | Royalty Pharma plc | A — Grant or award | 143.8K | $0.00 | |
| 2026-02-13 | RPRX | Royalty Pharma plc | A — Grant or award | 157.8K | $0.00 | |
| 2025-08-06 | RPRX | Royalty Pharma plc | A — Grant or award | 21.9K | $0.00 |
Pablo G. Legorreta is the CEO and Chairman of the Board of Royalty Pharma plc, a leading buyer of biopharmaceutical royalties. He has played a significant role in the company's growth and strategic direction since its founding.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Legorreta Pablo G. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.